The global Intracranial Therapeutic market was valued at million in 2024 and is projected to reach US$ million by 2032, at a CAGR of %during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
We have surveyed the Intracranial Therapeutic companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks
This report aims to provide a comprehensive presentation of the global market for Intracranial Therapeutic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Intracranial Therapeutic. This report contains market size and forecasts of Intracranial Therapeutic in global, including the following market information:
Global Intracranial Therapeutic market revenue, 2020-2025, 2026-2032, ($ millions)
Global top five Intracranial Therapeutic companies in 2024 (%)
Total Market by Segment:
Global Intracranial Therapeutic market, by Type, 2020-2025, 2026-2032 ($ millions)
Global Intracranial Therapeutic market segment percentages, by Type, 2024 (%)
Cell-based Therapy
Gene Therapy
Enzyme Replacement Therapy
Global Intracranial Therapeutic market, by Application, 2020-2025, 2026-2032 ($ millions)
Global Intracranial Therapeutic market segment percentages, by Application, 2024 (%)
Spinal Muscular Atrophy (SMA)
Multiple Sclerosis
Batten Disease
Amyotrophic Lateral Sclerosis
Global Intracranial Therapeutic market, by region and country, 2020-2025, 2026-2032 ($ millions)
Global Intracranial Therapeutic market segment percentages, by region and country, 2024 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Intracranial Therapeutic revenues in global market, 2020-2025 (estimated), ($ millions)
Key companies Intracranial Therapeutic revenues share in global market, 2024 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novartis AG
BioMarin
CORESTEM Inc.
Alaunos Therapeutics, Inc.
Apic Bio
Stemedica Cell Technologies, Inc.
Voyager Therapeutics
Bayer AG
Abeona Therapeutics
Spark Therapeutics
Outline of Major Chapters:
Chapter 1: Introduces the definition of Intracranial Therapeutic, market overview.
Chapter 2: Global Intracranial Therapeutic market size in revenue.
Chapter 3: Detailed analysis of Intracranial Therapeutic company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Intracranial Therapeutic in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Intracranial Therapeutic Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 Global Intracranial Therapeutic Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Intracranial Therapeutic Overall Market Size
2.1 Global Intracranial Therapeutic Market Size: 2024 VS 2032
2.2 Global Intracranial Therapeutic Market Size, Prospects & Forecasts: 2020-2032
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Intracranial Therapeutic Players in Global Market
3.2 Top Global Intracranial Therapeutic Companies Ranked by Revenue
3.3 Global Intracranial Therapeutic Revenue by Companies
3.4 Top 3 and Top 5 Intracranial Therapeutic Companies in Global Market, by Revenue in 2024
3.5 Global Companies Intracranial Therapeutic Product Type
3.6 Tier 1, Tier 2, and Tier 3 Intracranial Therapeutic Players in Global Market
3.6.1 List of Global Tier 1 Intracranial Therapeutic Companies
3.6.2 List of Global Tier 2 and Tier 3 Intracranial Therapeutic Companies
4 Sights by Product
4.1 Overview
4.1.1 Segmentation by Type - Global Intracranial Therapeutic Market Size Markets, 2024 & 2032
4.1.2 Cell-based Therapy
4.1.3 Gene Therapy
4.1.4 Enzyme Replacement Therapy
4.2 Segmentation by Type - Global Intracranial Therapeutic Revenue & Forecasts
4.2.1 Segmentation by Type - Global Intracranial Therapeutic Revenue, 2020-2025
4.2.2 Segmentation by Type - Global Intracranial Therapeutic Revenue, 2026-2032
4.2.3 Segmentation by Type - Global Intracranial Therapeutic Revenue Market Share, 2020-2032
5 Sights by Application
5.1 Overview
5.1.1 Segmentation by Application - Global Intracranial Therapeutic Market Size, 2024 & 2032
5.1.2 Spinal Muscular Atrophy (SMA)
5.1.3 Multiple Sclerosis
5.1.4 Batten Disease
5.1.5 Amyotrophic Lateral Sclerosis
5.2 Segmentation by Application - Global Intracranial Therapeutic Revenue & Forecasts
5.2.1 Segmentation by Application - Global Intracranial Therapeutic Revenue, 2020-2025
5.2.2 Segmentation by Application - Global Intracranial Therapeutic Revenue, 2026-2032
5.2.3 Segmentation by Application - Global Intracranial Therapeutic Revenue Market Share, 2020-2032
6 Sights by Region
6.1 By Region - Global Intracranial Therapeutic Market Size, 2024 & 2032
6.2 By Region - Global Intracranial Therapeutic Revenue & Forecasts
6.2.1 By Region - Global Intracranial Therapeutic Revenue, 2020-2025
6.2.2 By Region - Global Intracranial Therapeutic Revenue, 2026-2032
6.2.3 By Region - Global Intracranial Therapeutic Revenue Market Share, 2020-2032
6.3 North America
6.3.1 By Country - North America Intracranial Therapeutic Revenue, 2020-2032
6.3.2 United States Intracranial Therapeutic Market Size, 2020-2032
6.3.3 Canada Intracranial Therapeutic Market Size, 2020-2032
6.3.4 Mexico Intracranial Therapeutic Market Size, 2020-2032
6.4 Europe
6.4.1 By Country - Europe Intracranial Therapeutic Revenue, 2020-2032
6.4.2 Germany Intracranial Therapeutic Market Size, 2020-2032
6.4.3 France Intracranial Therapeutic Market Size, 2020-2032
6.4.4 U.K. Intracranial Therapeutic Market Size, 2020-2032
6.4.5 Italy Intracranial Therapeutic Market Size, 2020-2032
6.4.6 Russia Intracranial Therapeutic Market Size, 2020-2032
6.4.7 Nordic Countries Intracranial Therapeutic Market Size, 2020-2032
6.4.8 Benelux Intracranial Therapeutic Market Size, 2020-2032
6.5 Asia
6.5.1 By Region - Asia Intracranial Therapeutic Revenue, 2020-2032
6.5.2 China Intracranial Therapeutic Market Size, 2020-2032
6.5.3 Japan Intracranial Therapeutic Market Size, 2020-2032
6.5.4 South Korea Intracranial Therapeutic Market Size, 2020-2032
6.5.5 Southeast Asia Intracranial Therapeutic Market Size, 2020-2032
6.5.6 India Intracranial Therapeutic Market Size, 2020-2032
6.6 South America
6.6.1 By Country - South America Intracranial Therapeutic Revenue, 2020-2032
6.6.2 Brazil Intracranial Therapeutic Market Size, 2020-2032
6.6.3 Argentina Intracranial Therapeutic Market Size, 2020-2032
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Intracranial Therapeutic Revenue, 2020-2032
6.7.2 Turkey Intracranial Therapeutic Market Size, 2020-2032
6.7.3 Israel Intracranial Therapeutic Market Size, 2020-2032
6.7.4 Saudi Arabia Intracranial Therapeutic Market Size, 2020-2032
6.7.5 UAE Intracranial Therapeutic Market Size, 2020-2032
7 Companies Profiles
7.1 Novartis AG
7.1.1 Novartis AG Corporate Summary
7.1.2 Novartis AG Business Overview
7.1.3 Novartis AG Intracranial Therapeutic Major Product Offerings
7.1.4 Novartis AG Intracranial Therapeutic Revenue in Global Market (2020-2025)
7.1.5 Novartis AG Key News & Latest Developments
7.2 BioMarin
7.2.1 BioMarin Corporate Summary
7.2.2 BioMarin Business Overview
7.2.3 BioMarin Intracranial Therapeutic Major Product Offerings
7.2.4 BioMarin Intracranial Therapeutic Revenue in Global Market (2020-2025)
7.2.5 BioMarin Key News & Latest Developments
7.3 CORESTEM Inc.
7.3.1 CORESTEM Inc. Corporate Summary
7.3.2 CORESTEM Inc. Business Overview
7.3.3 CORESTEM Inc. Intracranial Therapeutic Major Product Offerings
7.3.4 CORESTEM Inc. Intracranial Therapeutic Revenue in Global Market (2020-2025)
7.3.5 CORESTEM Inc. Key News & Latest Developments
7.4 Alaunos Therapeutics, Inc.
7.4.1 Alaunos Therapeutics, Inc. Corporate Summary
7.4.2 Alaunos Therapeutics, Inc. Business Overview
7.4.3 Alaunos Therapeutics, Inc. Intracranial Therapeutic Major Product Offerings
7.4.4 Alaunos Therapeutics, Inc. Intracranial Therapeutic Revenue in Global Market (2020-2025)
7.4.5 Alaunos Therapeutics, Inc. Key News & Latest Developments
7.5 Apic Bio
7.5.1 Apic Bio Corporate Summary
7.5.2 Apic Bio Business Overview
7.5.3 Apic Bio Intracranial Therapeutic Major Product Offerings
7.5.4 Apic Bio Intracranial Therapeutic Revenue in Global Market (2020-2025)
7.5.5 Apic Bio Key News & Latest Developments
7.6 Stemedica Cell Technologies, Inc.
7.6.1 Stemedica Cell Technologies, Inc. Corporate Summary
7.6.2 Stemedica Cell Technologies, Inc. Business Overview
7.6.3 Stemedica Cell Technologies, Inc. Intracranial Therapeutic Major Product Offerings
7.6.4 Stemedica Cell Technologies, Inc. Intracranial Therapeutic Revenue in Global Market (2020-2025)
7.6.5 Stemedica Cell Technologies, Inc. Key News & Latest Developments
7.7 Voyager Therapeutics
7.7.1 Voyager Therapeutics Corporate Summary
7.7.2 Voyager Therapeutics Business Overview
7.7.3 Voyager Therapeutics Intracranial Therapeutic Major Product Offerings
7.7.4 Voyager Therapeutics Intracranial Therapeutic Revenue in Global Market (2020-2025)
7.7.5 Voyager Therapeutics Key News & Latest Developments
7.8 Bayer AG
7.8.1 Bayer AG Corporate Summary
7.8.2 Bayer AG Business Overview
7.8.3 Bayer AG Intracranial Therapeutic Major Product Offerings
7.8.4 Bayer AG Intracranial Therapeutic Revenue in Global Market (2020-2025)
7.8.5 Bayer AG Key News & Latest Developments
7.9 Abeona Therapeutics
7.9.1 Abeona Therapeutics Corporate Summary
7.9.2 Abeona Therapeutics Business Overview
7.9.3 Abeona Therapeutics Intracranial Therapeutic Major Product Offerings
7.9.4 Abeona Therapeutics Intracranial Therapeutic Revenue in Global Market (2020-2025)
7.9.5 Abeona Therapeutics Key News & Latest Developments
7.10 Spark Therapeutics
7.10.1 Spark Therapeutics Corporate Summary
7.10.2 Spark Therapeutics Business Overview
7.10.3 Spark Therapeutics Intracranial Therapeutic Major Product Offerings
7.10.4 Spark Therapeutics Intracranial Therapeutic Revenue in Global Market (2020-2025)
7.10.5 Spark Therapeutics Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Intracranial Therapeutic Market Opportunities & Trends in Global Market
Table 2. Intracranial Therapeutic Market Drivers in Global Market
Table 3. Intracranial Therapeutic Market Restraints in Global Market
Table 4. Key Players of Intracranial Therapeutic in Global Market
Table 5. Top Intracranial Therapeutic Players in Global Market, Ranking by Revenue (2024)
Table 6. Global Intracranial Therapeutic Revenue by Companies, (US$, Mn), 2020-2025
Table 7. Global Intracranial Therapeutic Revenue Share by Companies, 2020-2025
Table 8. Global Companies Intracranial Therapeutic Product Type
Table 9. List of Global Tier 1 Intracranial Therapeutic Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Intracranial Therapeutic Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 11. Segmentation by Type – Global Intracranial Therapeutic Revenue, (US$, Mn), 2024 & 2032
Table 12. Segmentation by Type - Global Intracranial Therapeutic Revenue (US$, Mn), 2020-2025
Table 13. Segmentation by Type - Global Intracranial Therapeutic Revenue (US$, Mn), 2026-2032
Table 14. Segmentation by Application– Global Intracranial Therapeutic Revenue, (US$, Mn), 2024 & 2032
Table 15. Segmentation by Application - Global Intracranial Therapeutic Revenue, (US$, Mn), 2020-2025
Table 16. Segmentation by Application - Global Intracranial Therapeutic Revenue, (US$, Mn), 2026-2032
Table 17. By Region– Global Intracranial Therapeutic Revenue, (US$, Mn), 2024 & 2032
Table 18. By Region - Global Intracranial Therapeutic Revenue, (US$, Mn), 2020-2025
Table 19. By Region - Global Intracranial Therapeutic Revenue, (US$, Mn), 2026-2032
Table 20. By Country - North America Intracranial Therapeutic Revenue, (US$, Mn), 2020-2025
Table 21. By Country - North America Intracranial Therapeutic Revenue, (US$, Mn), 2026-2032
Table 22. By Country - Europe Intracranial Therapeutic Revenue, (US$, Mn), 2020-2025
Table 23. By Country - Europe Intracranial Therapeutic Revenue, (US$, Mn), 2026-2032
Table 24. By Region - Asia Intracranial Therapeutic Revenue, (US$, Mn), 2020-2025
Table 25. By Region - Asia Intracranial Therapeutic Revenue, (US$, Mn), 2026-2032
Table 26. By Country - South America Intracranial Therapeutic Revenue, (US$, Mn), 2020-2025
Table 27. By Country - South America Intracranial Therapeutic Revenue, (US$, Mn), 2026-2032
Table 28. By Country - Middle East & Africa Intracranial Therapeutic Revenue, (US$, Mn), 2020-2025
Table 29. By Country - Middle East & Africa Intracranial Therapeutic Revenue, (US$, Mn), 2026-2032
Table 30. Novartis AG Corporate Summary
Table 31. Novartis AG Intracranial Therapeutic Product Offerings
Table 32. Novartis AG Intracranial Therapeutic Revenue (US$, Mn) & (2020-2025)
Table 33. Novartis AG Key News & Latest Developments
Table 34. BioMarin Corporate Summary
Table 35. BioMarin Intracranial Therapeutic Product Offerings
Table 36. BioMarin Intracranial Therapeutic Revenue (US$, Mn) & (2020-2025)
Table 37. BioMarin Key News & Latest Developments
Table 38. CORESTEM Inc. Corporate Summary
Table 39. CORESTEM Inc. Intracranial Therapeutic Product Offerings
Table 40. CORESTEM Inc. Intracranial Therapeutic Revenue (US$, Mn) & (2020-2025)
Table 41. CORESTEM Inc. Key News & Latest Developments
Table 42. Alaunos Therapeutics, Inc. Corporate Summary
Table 43. Alaunos Therapeutics, Inc. Intracranial Therapeutic Product Offerings
Table 44. Alaunos Therapeutics, Inc. Intracranial Therapeutic Revenue (US$, Mn) & (2020-2025)
Table 45. Alaunos Therapeutics, Inc. Key News & Latest Developments
Table 46. Apic Bio Corporate Summary
Table 47. Apic Bio Intracranial Therapeutic Product Offerings
Table 48. Apic Bio Intracranial Therapeutic Revenue (US$, Mn) & (2020-2025)
Table 49. Apic Bio Key News & Latest Developments
Table 50. Stemedica Cell Technologies, Inc. Corporate Summary
Table 51. Stemedica Cell Technologies, Inc. Intracranial Therapeutic Product Offerings
Table 52. Stemedica Cell Technologies, Inc. Intracranial Therapeutic Revenue (US$, Mn) & (2020-2025)
Table 53. Stemedica Cell Technologies, Inc. Key News & Latest Developments
Table 54. Voyager Therapeutics Corporate Summary
Table 55. Voyager Therapeutics Intracranial Therapeutic Product Offerings
Table 56. Voyager Therapeutics Intracranial Therapeutic Revenue (US$, Mn) & (2020-2025)
Table 57. Voyager Therapeutics Key News & Latest Developments
Table 58. Bayer AG Corporate Summary
Table 59. Bayer AG Intracranial Therapeutic Product Offerings
Table 60. Bayer AG Intracranial Therapeutic Revenue (US$, Mn) & (2020-2025)
Table 61. Bayer AG Key News & Latest Developments
Table 62. Abeona Therapeutics Corporate Summary
Table 63. Abeona Therapeutics Intracranial Therapeutic Product Offerings
Table 64. Abeona Therapeutics Intracranial Therapeutic Revenue (US$, Mn) & (2020-2025)
Table 65. Abeona Therapeutics Key News & Latest Developments
Table 66. Spark Therapeutics Corporate Summary
Table 67. Spark Therapeutics Intracranial Therapeutic Product Offerings
Table 68. Spark Therapeutics Intracranial Therapeutic Revenue (US$, Mn) & (2020-2025)
Table 69. Spark Therapeutics Key News & Latest Developments
List of Figures
Figure 1. Intracranial Therapeutic Product Picture
Figure 2. Intracranial Therapeutic Segment by Type in 2024
Figure 3. Intracranial Therapeutic Segment by Application in 2024
Figure 4. Global Intracranial Therapeutic Market Overview: 2024
Figure 5. Key Caveats
Figure 6. Global Intracranial Therapeutic Market Size: 2024 VS 2032 (US$, Mn)
Figure 7. Global Intracranial Therapeutic Revenue: 2020-2032 (US$, Mn)
Figure 8. The Top 3 and 5 Players Market Share by Intracranial Therapeutic Revenue in 2024
Figure 9. Segmentation by Type – Global Intracranial Therapeutic Revenue, (US$, Mn), 2024 & 2032
Figure 10. Segmentation by Type - Global Intracranial Therapeutic Revenue Market Share, 2020-2032
Figure 11. Segmentation by Application – Global Intracranial Therapeutic Revenue, (US$, Mn), 2024 & 2032
Figure 12. Segmentation by Application - Global Intracranial Therapeutic Revenue Market Share, 2020-2032
Figure 13. By Region - Global Intracranial Therapeutic Revenue Market Share, 2020-2032
Figure 14. By Country - North America Intracranial Therapeutic Revenue Market Share, 2020-2032
Figure 15. United States Intracranial Therapeutic Revenue, (US$, Mn), 2020-2032
Figure 16. Canada Intracranial Therapeutic Revenue, (US$, Mn), 2020-2032
Figure 17. Mexico Intracranial Therapeutic Revenue, (US$, Mn), 2020-2032
Figure 18. By Country - Europe Intracranial Therapeutic Revenue Market Share, 2020-2032
Figure 19. Germany Intracranial Therapeutic Revenue, (US$, Mn), 2020-2032
Figure 20. France Intracranial Therapeutic Revenue, (US$, Mn), 2020-2032
Figure 21. U.K. Intracranial Therapeutic Revenue, (US$, Mn), 2020-2032
Figure 22. Italy Intracranial Therapeutic Revenue, (US$, Mn), 2020-2032
Figure 23. Russia Intracranial Therapeutic Revenue, (US$, Mn), 2020-2032
Figure 24. Nordic Countries Intracranial Therapeutic Revenue, (US$, Mn), 2020-2032
Figure 25. Benelux Intracranial Therapeutic Revenue, (US$, Mn), 2020-2032
Figure 26. By Region - Asia Intracranial Therapeutic Revenue Market Share, 2020-2032
Figure 27. China Intracranial Therapeutic Revenue, (US$, Mn), 2020-2032
Figure 28. Japan Intracranial Therapeutic Revenue, (US$, Mn), 2020-2032
Figure 29. South Korea Intracranial Therapeutic Revenue, (US$, Mn), 2020-2032
Figure 30. Southeast Asia Intracranial Therapeutic Revenue, (US$, Mn), 2020-2032
Figure 31. India Intracranial Therapeutic Revenue, (US$, Mn), 2020-2032
Figure 32. By Country - South America Intracranial Therapeutic Revenue Market Share, 2020-2032
Figure 33. Brazil Intracranial Therapeutic Revenue, (US$, Mn), 2020-2032
Figure 34. Argentina Intracranial Therapeutic Revenue, (US$, Mn), 2020-2032
Figure 35. By Country - Middle East & Africa Intracranial Therapeutic Revenue Market Share, 2020-2032
Figure 36. Turkey Intracranial Therapeutic Revenue, (US$, Mn), 2020-2032
Figure 37. Israel Intracranial Therapeutic Revenue, (US$, Mn), 2020-2032
Figure 38. Saudi Arabia Intracranial Therapeutic Revenue, (US$, Mn), 2020-2032
Figure 39. UAE Intracranial Therapeutic Revenue, (US$, Mn), 2020-2032
Figure 40. Novartis AG Intracranial Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 41. BioMarin Intracranial Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 42. CORESTEM Inc. Intracranial Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 43. Alaunos Therapeutics, Inc. Intracranial Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 44. Apic Bio Intracranial Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 45. Stemedica Cell Technologies, Inc. Intracranial Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 46. Voyager Therapeutics Intracranial Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 47. Bayer AG Intracranial Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 48. Abeona Therapeutics Intracranial Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 49. Spark Therapeutics Intracranial Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
